Oncology Nursing Update: Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy
Update: 2025-09-20
Description
Featuring an interview with Dr Beth Faiman, including the following topics:
- Clinical practice background and historical view of treatment for multiple myeloma (MM) (0:00 )
- Fundamental principles associated with chimeric antigen receptor (CAR) T-cell therapy (7:19 )
- Sequencing of CAR T-cell therapy and bispecific antibodies in the MM treatment landscape (9:00 )
- Patient eligibility to receive CAR T-cell therapy (13:23 )
- Differentiating among approved CAR T-cell therapies for MM (18:18 )
- Durability of responses to CAR T-cell therapy for MM (24:01 )
- Neurotoxicity with CAR T-cell therapies for MM (26:26 )
- Minimal residual disease monitoring in MM (29:39 )
- Support systems for the management of toxicities associated with CAR T-cell therapy (35:10 )
- Patients with MM experiencing durable responses to CAR T-cell therapy (43:11 )
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
